Search by Drug Name or NDC

    NDC 64764-0145-05 ADZYNMA Details

    ADZYNMA

    ADZYNMA is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by TAKEDA PHARMACEUTICALS AMERICA, INC.. The primary component is .

    Product Information

    NDC 64764-0145
    Product ID 64764-145_325b9c3f-c547-44ed-b8c1-c5abe8b3da53
    Associated GPIs
    GCN Sequence Number 085501
    GCN Sequence Number Description ADAMTS13, recombinant-krhn KIT 1500 UNIT INTRAVEN
    HIC3 Z26
    HIC3 Description AGENTS TO TX THROMBOTIC THROMBOCYTOPENIC PURPURA
    GCN 55003
    HICL Sequence Number 049300
    HICL Sequence Number Description ADAMTS13, RECOMBINANT-KRHN
    Brand/Generic Brand
    Proprietary Name ADZYNMA
    Proprietary Name Suffix n/a
    Non-Proprietary Name Apadamtase Alfa
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name TAKEDA PHARMACEUTICALS AMERICA, INC.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125795
    Listing Certified Through 2024-12-31

    Package

    NDC 64764-0145-05 (64764014505)

    NDC Package Code 64764-145-05
    Billing NDC 64764014505
    Package 1 KIT in 1 CARTON (64764-145-05) * 1500 [iU] in 1 VIAL, SINGLE-DOSE (64764-135-01) * 5 mL in 1 VIAL, GLASS (64764-515-50)
    Marketing Start Date 2023-11-09
    NDC Exclude Flag N
    Pricing Information N/A